By PPN News Staff
Hospira issued a voluntary recall of one of its naloxone products because of it might contain loose particulate matter, according to the FDA.
They recalled lots 72680LL and 76510LL of naloxone hydrochloride injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). The FDA said that distributors should stop distribution and quarantine the lots immediately.
Although there have been no reports of adverse events as a